Ultragenyx Pharmaceutical (RARE) Depreciation & Amortization (CF) (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Depreciation & Amortization (CF) of $8 million in Q2 2026, down 11.1% from $9 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
On a TTM basis, Ultragenyx Pharmaceutical's Depreciation & Amortization (CF) came in at $33 million as of Jun 30, 2026, down 9.1% year-over-year; for FY2025, it came in at $35 million, down 2.8% from FY2024.
- Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 23.3% (FY2020 to FY2025).
- Across earlier years, Depreciation & Amortization (CF) came in at $36 million in FY2024 (+38.5%), $26 million in FY2023 (+42.7%), $18.22 million in FY2022 (+37.6%) and $13.24 million in FY2021 (+8.0%).
- Quarterly Depreciation & Amortization (CF) has ranged from $3.22 million in Q3 2021 to $9.54 million in Q4 2024 over the past five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined for four consecutive quarters, with growth averaging 0.6% over the last eight quarters.
- Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 68.9% in Q1 2024, against a decline of 11.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $8 million (Q1 2026), $8.79 million (Q4 2025) and $8.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | 8.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 8.79 Mn |
| Sep 30, 2025 | 8.22 Mn |
| Jun 30, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 8.76 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | 7.19 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 4.96 Mn |
| Sep 30, 2022 | 4.69 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Mar 31, 2022 | 4.09 Mn |
| Dec 31, 2021 | 3.53 Mn |
| Sep 30, 2021 | 3.22 Mn |
API Access
Ultragenyx Pharmaceutical Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();